Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.5 EUR | -3.51% | -2.48% | -37.07% |
May. 07 | Talea Group launches its private label branded Farmaè | AN |
Apr. 23 | Talea closes first quarter with revenues up | AN |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company shows low valuation levels, with an enterprise value at 0.43 times its sales.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Internet Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-37.07% | 41.89M | - | ||
-6.79% | 193B | C | ||
+2.52% | 191B | C- | ||
+43.96% | 89.97B | B | ||
+7.88% | 87.04B | B | ||
-19.83% | 80.84B | B- | ||
+12.78% | 53.03B | B- | ||
+15.41% | 25.17B | B- | ||
+25.89% | 10.95B | B+ | ||
-10.81% | 8.63B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- FAR Stock
- Ratings Talea Group S.p.A.